AI Training Dataset Market Worth $4.8 Billion By 2027

The global AI training dataset market size is expected to reach USD 4.8 billion by 2027, expanding at a CAGR of 22.5%, according to a new report by Grand View Research, Inc. The artificial intelligence technology is proliferating. As organizations are transitioning towards automation, the demand for technology is rising. The technology has provided unprecedented advances across various industry verticals, including marketing, healthcare, logistics, transportation, and many others. The benefits of integrating the technology across various operations of the organizations have outweighed its costs, thereby driving adoption.

Due to the rapid adoption of artificial intelligence technology, the need for training sets is rising exponentially. To make the technology more versatile and accurate with its predictions, a wide number of companies are entering the market space by releasing various datasets operating across various use cases to train the machine learning algorithm. Such factors are substantially contributing to market growth.

Factors such as cultivation of new high-quality datasets to speed up the development of AI technology and deliver accurate results are driving the market. For instance, in January 2019, IBM Corporation, a technology company, announced the release of a new dataset that comprises of 1.0 million images of faces. This dataset was released with an aim to help developers to train their face recognition systems supported by artificial intelligence technology with diverse dataset. In addition, it will help developers to increase the accuracy of face identification.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/ai-training-dataset-market

Further key findings from the study suggest:

  • Increasing creation of synthetic training data for unsupervised and supervised training of machine learning algorithm is driving the adoption of datasets by organizations thereby catalyzing market growth
  • The image/video segment is expected to portray high growth rate of more than 25.0% over the projected period
  • In Asia Pacific, the market is expected to have significant growth over the forecast period, owing to the substantial adoption of AI technology
  • The key players in the market areGoogle, LLC (Kaggle); Appen Limited; Cogito Tech LLC; Lionbridge Technologies, Inc.; Amazon Web Services, Inc.; Microsoft Corporation; Scale AI; Inc.; Samasource Inc.; Alegion; and Deep Vision Data.

Pulmonary Arterial Hypertension Market Size Worth $9.8 Billion By 2027

The global pulmonary arterial hypertension market size is expected to reach USD 9.8 billion by 2027, according to a new report by Grand View Research, Inc., registering a CAGR of 5.6% over the forecast period. Increasing prevalence rates of pulmonary arterial hypertension (PAH) and government support for the development of orphan drugs drive the market growth.

The cases of PAH are rising in the range of 100,000 to 200,000 per year. However, in the past few years, the occurrence of PAH has been increasing due to risk factors such as alcohol/tobacco consumption, HIV, sedentary lifestyle, smoking, and other idiopathic conditions. Moreover, the geriatric population is more prone to PAH and associated diseases owing to reduced immune function. According to the National Council on Aging (NCOA), about 80 percent of the population aged 65 and above have at least one chronic condition such as high cholesterol, diabetes, heart or kidney disease, or chronic obstructive pulmonary disease.

Government initiatives such as the Rare Disease Act 2002 and The Orphan Drug Act (ODA) 1983, are also anticipated to support the market for treatment drugs for PAH. These acts play a significant role in promoting the ethical usage and distribution of orphan drugs. The development of orphan drugs is promoted by the National Organization of Rare Disorders.

Robust drug pipeline and new product combinations awaiting approval or launch are anticipated to increase the PAH market competitiveness over the forecast period. In September 2019, Acceleron Pharma, a leading biopharmaceutical company, received FDA orphan drug designation for sotatercept for the treatment of pulmonary arterial hypertension.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/pulmonary-arterial-hypertension-market

Further key findings from the report suggest:

  • Prostacyclin and its analogs for treating PAH are projected to show lucrative growth over the forecast period. The sales of these drugs are anticipated to increase due to the growing use of oral prostacyclin agents
  • North America dominated the PAH market with a share of over 55.0% in 2019. This is attributed to the well-established infrastructure for the development and distribution of high-quality therapies and the availability of reimbursement for PAH therapies
  • Asia Pacific is estimated to register the highest CAGR of more than 6.0% over the forecast period due to its huge population base, rapid economic development, and improving healthcare system. Moreover, the high burden of diseases such as HIV in the region contribute to the development of PAH
  • The major players in the pulmonary arterial hypertension market that offer treatment solutions for PAH include GlaxoSmithKline plc; Johnson & Johnson Services, Inc. (Actelion Pharmaceuticals, Ltd.); United Therapeutics Corporation; Pfizer, Inc.; and Gilead Sciences, Inc. The market is consolidated and competitive in nature. The players enjoy the benefit of high entry barriers to other firms due to high price interdependency

Next Generation Sequencing Market Size Worth $23.7 Billion By 2027

The global next generation sequencing market size is expected to reach USD 23.7 billion by 2027, expanding at a CAGR of 11.7%, according to a new report by Grand View Research, Inc. Numerous advantages offered by high throughput sequencing over other genetic technologies such as sanger-seq and microarray is one of the key driving forces of the market for Next Generation Sequencing (NGS). Furthermore, increasing availability of low input DNA sampling methods that decrease the overall operational costs is anticipated to accelerate the use of next generation sequencing across various research and clinical applications.

Technology offered by New England Biolabs that employs magnetic beads in the template assembly process is anticipated to significantly improve the sample preparation protocols for next generation sequencing. Furthermore, recent technological advancements such as the use of Laboratory Information Management System (LIMS) for genome library automation allow next generation sequencing in a single day at a reasonable cost. These advancements are anticipated to proliferate the number of users of next generation sequencing over the forecast period.

This technology has captured the attention of several companies and investors operating across various domains including basic research, drug discovery and development, reproductive health, and consumer genomics. In addition, the plummeting cost and the added value of next generation sequencing data over conventional ones is anticipated to positively impact the diversification of this technology in other clinical areas, resulting into a lucrative revenue growth.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/next-generation-sequencing-market

Further key findings from the report suggest:

  • In 2019, oncology was estimated as the application with the largest revenue share in the market for next generation sequencing
  • This can be attributed to the fact that the technology has been largely adopted to decipher the link between cancer and genetics
  • Moreover, NGS-based genetic testing for cancer predisposition can significantly improve the health outcome and reduce the mortality rate, thereby driving adoption in this segment
  • The targeted sequencing segment has dominated the revenue share owing to its various benefits over the whole genome segment with respect to the depth of coverage and multiplexing capacities
  • Significant price drop in sequencing the whole genome is anticipated to drive the segment at a lucrative growth rate
  • Based on workflow, sequencing accounted for the major revenue share in 2019 in the market for next generation sequencing and is anticipated to maintain its dominance over the forecast period
  • Being a key step, the end-users are making major investments in the seq-step, compared to sample preparation and data analysis
  • Moreover, the key developers are engaged in introducing new seq-platforms with enhanced capabilities and efficiency. These factors have led the segment in terms of revenue over the past years
  • Academic research entities are the largest end-users in terms of revenue generation owing to the high penetration of seq-technology in research activities
  • On the other hand, this technology is making continued growth in clinical research and within clinical settings
  • A substantial number of researchers are engaged in conducting translational research to accelerate the adoption of seq-technology in clinical diagnostics
  • North America accounted for the maximum revenue share owing to the presence of integrated platform base in U.S.
  • Presence of Illumina, the major player of next generation sequencing market for U.S. is another major factor that has driven the revenue share of this region in the past years
  • Asia Pacific is projected to mark fastest growth owing to the increase in number of domestic developers in China coupled with the expansion of molecular diagnostics area
  • Some major participants in the market for next generation sequencing are Illumina Inc.; F Hoffman-La Roche Ltd.; QIAGEN; Thermo Fisher Scientific Inc.; and BGI
  • The companies are collaborating with diagnostic players to extend the use of their platforms in clinical settings
  • For instance, Illumina has partnered with China’s KingMed Diagnostics for use of its platform in oncology and hereditary disease testing.

MRI Market Size Worth $8.18 Billion By 2027

The global magnetic resonance imaging market size is expected to reach USD 8.18 billion by 2027, registering a revenue-based CAGR of 5.9% during the forecast period, according to Grand View Research, Inc. Rising prevalence of chronic diseases coupled with increasing demand for early diagnostic techniques is projected to drive the growth. In addition, growing adoption of less invasive diagnostic procedures is contributing to the magnetic resonance imaging (MRI) market growth. Moreover, increasing number of clinical trials to understand the effectiveness and efficiency of MRI machines in various clinical applications is expected to boost the growth.

End-users, such as research institutes and universities are frequently studying the efficiency of MRI devices with high field strength such as 7T, 10T, and 10.5T. Growing number of research studies will help unlock the potential usage and advantages of high field MRI machines for various preclinical as well as clinical applications. Currently, 7T MRI machines are only effective in brain and knee imaging, largely due to the absence of advance coil required for these high field machines. Therefore, the development of advance coils to expand the application of 7T MRI machines is expected to propel the growth during the forecast period.

Key market players are adopting various strategies, such as mergers and acquisitions, collaborations, and partnerships to gain competitive edge. For instance, Aurora Imaging Technology entered into a distribution agreement with Sumec Group Corporation. Under this distribution agreement, the latter will distribute MRI portfolio of Aurora Imaging Technology in China. This in turn is helping both the companies in geographical expansion.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/magnetic-resonance-imaging-market

Further key findings from the report suggest:

  • Open system is anticipated to be the fastest growing segment during the forecast period due to its efficiency to accommodate patients of all sizes without them feeling claustrophobic
  • Magnetic resonance imaging (MRI) market for neurological and brain disorders held the dominant market share in 2019, largely due to high prevalence of neurological conditions and demand for less invasive diagnostic procedure
  • The high field MRI segment is expected to experience fastest growth over the forecast period, largely due to efficiency of the field strength to provide detailed diagnostic images
  • Ambulatory Surgical Centers (ASC) are expected to exhibit the fastest CAGR during the forecast period. Government initiatives to improve primary care is one of the major factor impacting the growth
  • In 2019, North America dominated the global MRI market in terms of revenue, owing to continuous research activities and high adoption of advanced techniques
  • Asia Pacific is anticipated to expand at the fastest CAGR during the forecast period, largely due to a rise in clinical studies for high field MRI machines

Digital Pathology Market Worth $1.86 Billion By 2027

The global digital pathology market size is expected to reach USD 1.86 billion by 2027, registering a CAGR of 11.8% over the forecast period, according to a new report published by Grand View Research, Inc. Increasing prevalence of chronic diseases triggers the demand for advanced diagnostics, which is expected to drive the market growth. Growing economic stability and awareness pertaining to the benefits of using Computer-Aided Diagnostics (CAD) is further contributing to the growth.

Technological advancements, such as digital imaging, computerization, robotic light microscopy, and multiple fiber optic communications are some of the key factors driving the adoption of digital pathology. In addition, the introduction of cloud-based technology enabling storage of digital slides coupled with secure access to pathologists is expected to serve as a potential growth driver for the market.

Digital pathology has an important role in companion diagnostics and drug development pipeline, including molecular biology, biobanking, molecular tissue profiling, and tissue microarray analysis. Increasing demand for high-quality tissue samples in tissue-based biomarker research is expected to propel the adoption of the technology over the forecast period.

The market is expected to witness intense competition in near future owing to the rising adoption of rigorous strategies by the market players to sustain competition. For instance; whole slide imaging system manufacturers focus on obtaining premarket approval for diagnostic digital systems to capture greater revenue share.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/digital-pathology-systems-market

Further Key Findings From the Report Suggest:

  • Devices held the dominant market share in 2019 owing to increased use in academic research
  • The rising implementation of slide management system in stratified medicine and tissue-based biomarker research is one of the key contributing factors for the dominance of this technology
  • The software segment is expected to witness lucrative growth in the near future as the product assists in faster diagnosis and synchronization of patient data, where healthcare professionals can remotely access this information
  • Digital pathology is increasingly used in academic research owing to various benefits, such as cost-effectiveness and rapid results
  • The disease diagnosis segment is expected to witness lucrative growth over the forecast period owing to the increasing prevalence of cancer and demand for noble diagnosis techniques
  • The availability of unified platforms for workflows in pathology is anticipated to boost the usage of computer-aided imaging technology in academic research, which is anticipated to boost the segment growth
  • Hospital led the end-use segment in 2019 owing to the increasing adoption of digital pathology
  • The digital pathology market is expected to remain innovation-led, with frequent acquisitions and strategic alliances. New product development and well-established distribution channels are key to the competitive advantage of leading players
  • An increasing usage rate of the digital imaging systems to facilitate faster diagnosis, particularly of chronic diseases; the increased uptake of these products serves as the key driver of this market

Africa Roaming Tariff Market Worth $2.5 Billion By 2027

The Africa roaming tariff market size is anticipated to reach USD 2.5 billion by 2027, growing at a CAGR of 5.5%, according to a study conducted by Grand View Research, Inc. Roaming tariff are the charges incurred by the operator in return of roaming services, that allow the customers to use communication devices outside the geographical coverage area provided by the network operator. Increasing count of mobile phone users in urban as well as rural regions across Africa is expected to drive the market. Moreover, increasing international tourism is projected to escalate market growth in the forecast period.

Rising number of smartphone and internet users is also expected to bolster market growth in the region. Moreover, the adoption of 3G, 4G, and 5G technologies in Africa is expected to increase in the coming years, which is also projected to fuel market growth. For instance, according to the GSM Association (GSMA), the count of unique mobile subscribers will increase by up to 623 million in 2025 from 456 million in 2018. Additionally, mobile internet users are expected to have a 39.0% penetration rate and can reach up to 483 million subscribers by the end of 2025.

According to the GSM Association, Africa is amongst the rapidly growing mobile market across the globe. GSMA also states that the count of international travelers is increasing in the region at a larger extent, which in turn escalates market growth. Rising technological awareness among users has enabled service providers to introduce technological advancements, thereby resulting in market growth. Moreover, growing population in the region has paved way for growth of subscriber base of mobile phone operators, which is one of the additional factors expected to fuel the growth of the market in the region.

Technical barriers such as interoperability, due to the use of different GSM/3G spectrum, can restrict many low-cost handsets from roaming, and the network coverage, mainly 3G continues to remain underdeveloped as operators continue to upgrade to new technology and roll out the older. Whereas, the introduction of roaming regulations such as, pricing regulations, taxation related policies are anticipated to hinder market growth. However, substantial investments from operators in order to provide consistent services to users are projected to propel market growth. Similarly, significant investments from communication service providers are also expected to reduce the intensity of the aforementioned restraints, thereby positively impacting the market in the region.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/africa-roaming-tariff-market

Further key findings from the study suggest:

  • The national roaming segment is expected to continue its dominance over the forecast period owing to the demographic bulge. Growing count of young consumers in the region also escalates the growth of the segment, as the youth is more leaned towards usage of smartphones and internet in the region
  • International roaming segment is expected to witness a highest CAGR from 2020 to 2027. This is attributed to rising international tourism
  • Wholesale roaming is expected to account for revenue share of over USD 2.0 billion by 2027 owing to increasing adoption of service in the medium and large enterprises in the region
  • The voice service type of the Africa roaming tariff market is the major shareholder amid other services such as data, and SMS. The voice service market is expected to exceed USD 1,200 million by the end of 2027
  • The key players operating in the market are America Movil, AT&T Inc., Bharti Airtel Ltd., China Mobile Ltd, Deutsche Telekom AG, Digicel Group and others

Point Of Sale Software Market Size Worth $18.1 Billion By 2027

The global point of sale software market size is expected to reach USD 18.1 billion by 2027, registering a CAGR of 10.1% over the forecast period, according to a new report by Grand View Research, Inc. The market is expected to witness substantial growth owing to increasing need for compatible software for point of sale system’s functioning. Point-of-Sale (POS) software facilitates functions such as inventory management, authorize cards payment, collect signatures and e-mail receipts, and manage employees and business operations to minimize human intervention and ensure smooth running of all processes.

POS software is used across different end-user industries for processing payments, bookkeeping, invoicing, tracking orders, and other functions. However, the functionality may significantly vary depending upon the end-user industry requirement. For instance, the restaurant POS software requires specific features such as order, inventory, table management, and employee scheduling to meet the needs of different restaurant types, which is not needed in retail or healthcare. Hence, increasing demand for customized POS software in restaurant, retail, hospitality, healthcare, entertainment business, and other industries is expected to boost the point of sale software market over the forecast period.

POS software for a fixed POS terminal has been used for decades and is trusted across all large business sectors due to its ability to provide robust business functions and management of inventory, loyalty programs and gift cards, credit/debit card payment, employee attendance, and cash drawer for large enterprises. While small and medium enterprises have largely opted for mobile POS software owing to its convenience in business to allow credit or debit card payments virtually as well as at any location on-the-go.

Point of sale system has become an integral part of the small and medium business environment to process sales securely, carry out the administrative task, and provide a seamless customer experience. Substantial growth of this segment is attributed to increasing adoption of cloud-based mobile POS solution by the small businesses having software packages such as payment processing, inventory management, payroll, and accounting to manage their day to day business operations.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/point-of-sale-pos-software-market

Further key findings from the report suggest:

  • The on-premise segment dominated the market in 2019 in terms of revenue and is estimated to reach USD 11.4 billion by 2027. High demand for on-premise deployment is due to data security concerns, as the customer data can be vulnerable to cyber-attack when exposed to third party or unknown sources
  • The mobile POS segment is anticipated to witness the highest CAGR of 13.2% over the forecast period owing to increasing demand in restaurant and retail for quick payment and portability
  • The market in the Asia Pacific region is expected to register the highest CAGR over the forecast period owing to growing demand for advanced features across end-use industries including retail and restaurant in countries such as China and India
  • Some of the major players in the point of sale software market are NCR Corporation; Revel Systems; Oracle; Agilysys, Inc.; Clover Network, Inc.; Diebold Nixdorf, Incorporated; Epicor Software Corporation; Ingenico Group; Intuit, Inc.; Lightspeed; PAR Technology Corp.; SAP; Toshiba Tec Corporation; ShopKeep; and Toast, Inc.

Interactive Tables Market Size Worth $1.5 Billion By 2027

The global interactive tables market size is expected to reach USD 1.5 billion by 2027, registering a CAGR of 7.2% over the forecast period, according to a new study by Grand View Research, Inc. Implementation of multi-touch technology in the education sector is expected to drive the market over the forecast period. Growing demand for digital classrooms that allow numerous students to work together for cooperative learning is expected to boost market growth.

Interactive tables are also extensively used in trade shows and exhibitions that require the display to be clear as well as allow multi-touch. 32 to 65 inch tables are witnessing increased demand among the exhibitions as they provide better clarity and are highly portable.

Furthermore, growth of the market is attributed to emergence of various interactive display technologies, especially in North America. Besides, the hospitality sector is witnessing a paradigm shift in terms of the transportation sector, including train stations, airports, and public places. At such public places, visitors and travelers can get personalized information, such as booking & check-in, social media sharing, and special offers, at interactive info screens and kiosk terminals.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/interactive-tables-market

Further key findings from the study suggest:

  • The market is anticipated to witness substantial growth in the coming years owing to rising significance of gamification in the education system and adoption of interactive tables in the hospitality sector
  • Based on technology, the capacitive segment accounted for the largest market share in 2019 owing to improved touch technology and distance sensing
  • By screen size, 32 to 65 inch tables captured a significant market share in 2019 and are witnessing high demand across various sectors as they are portable and easy to carry from one place to another
  • The interactive tables market in North America is expected to witness significant growth owing to the presence of a large number of restaurants using interactive technologies, coupled with strong presence of touch table solution providers in U.S.
  • Key players in the market include Box Light Corporation, DigaliX, eyefactive GmbH, Garamantis GmbH, and HORIZON DISPLAY, LLC.

Trade Surveillance Market Worth $2.9 Billion By 2027

The global trade surveillance market size is expected to reach USD 2.9 billion by 2027, registering a CAGR of 19.7% over the forecast period, according to a new report by Grand View Research, Inc. Increasing need for monitoring trade activities in financial institutions, consulting firms, and government regulatory offices is considered to be the primary factor for the market growth. The market growth is ascribed to rising pressure on financial markets to adhere to the regulations and compliances. 

At the government level, regulatory agencies such as the Commodity Futures Trading Commission (CFTC) and the Securities and Exchange Commission (SEC) provide trade surveillance system to help maintain securities laws and protect investors against fraud. Furthermore, the benefits such as improved workflow management and internal control are also anticipated to increase the demand for trade surveillance in these regulatory agencies over the forecast period.

Furthermore, the market is also driven by increasing number of insurance businesses and rising demand for advanced banking solutions, especially in Asia Pacific, which currently accounts for the second-fastest growth. Furthermore, Asia Pacific has a substantial impact on the market misconduct and cross-border trading, which in turn is boosting the trade surveillance market growth in this region.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/trade-surveillance-market

Further key findings from the study suggest:

  • The market is anticipated to witness substantial growth during the forecast period owing to rising adoption among various end users including government regulators, market operators, and IT services providers
  • The solutions segment accounted for the highest market share in 2019 owing to the associated benefits such as optimization of surveillance data, enhancement of compliance management, and streamlining of case management
  • The on-premises deployment segment accounted for the largest share due to various benefits such as easy integration with the existing IT infrastructure of the enterprise and high level of data security
  • Europe is anticipated to register a significant growth and dominate the market in the forecast period owing to extensive adoption of cloud-based trade surveillance systems by various enterprises and trading regulations imposed by the government
  • Key players in the trade surveillance market include NICE Systems; Crisil Limited; Aquis Technologies; Scila; OneMarketData, LLC; IPC System, Inc.; B-Next; ACA Compliance Group; Red Deer (Jersey) Ltd.; Nasdaq, Inc.; and SIA S.P.A. 

Active Pharmaceutical Ingredients Market Worth $286.6 Billion By 2027

The global active pharmaceutical ingredient market size is expected to reach a value of USD 286.6 billion by 2027, according to a new report by Grand View Research, Inc., registering a CAGR of 6.7% over the forecast period. Factors, such as increasing preference for outsourcing APIs and growing prevalence of various target diseases such as cancer and Cardiovascular Diseases (CVDs) are expected to drive the market growth.

A steady rise in consumer demand for APIs, especially in developing and under-developed countries, increases the adoption of these products. In addition, strategic collaborations play a key role in the adoption of these ingredients in various regions. For instance, in February 2019, Cipla Inc. partnered with Wellthy Therapeutics Private Limited to combine digital therapeutics and pharmacotherapy for better patient outcomes in cardiovascular diseases and diabetes.

Private and public initiatives to manufacture active pharmaceutical ingredients within their countries, especially in developing countries such as India, is expected to drive the growth of the market. For instance, API production in India is promoted under the “Make in India” initiative.

Presence of prominent players and increasing government initiatives for the development of pharmaceuticals in various regions are also expected to boost the market growth. Increasing consumer awareness and demand for economical and effective treatment strategies, especially in Asia Pacific and Middle East and Africa, are driving the sales channels. In addition, high adoption and growing usage of online pharmacies are likely to drive the e-commerce sales of APIs.

The API market is competitive in nature and is becoming increasingly competitive. Consequently, manufacturers are required to enhance products in order to gain advantage over previously marketed products. For instance, in March 2019, Dr. Reddy’s Laboratories Ltd. launched XCEED-a B2B customer service portal. The platform was designed to manage the growing demand for generic active pharmaceutical ingredients by significantly increasing operational efficiency.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/active-pharmaceutical-ingredients-market

Further key findings from the report suggest:

  • On the basis of type of synthesis, the synthetic segment dominated the active pharmaceutical ingredients market in 2019 owing to easy availability of raw materials and easier protocols in place for the synthesis of these molecules
  • The biotech segment is estimated to register the highest CAGR owing to higher efficiency of these molecules and increasing demand for biopharmaceuticals
  • Captive manufacturers held the largest share in 2019 due to easy availability of raw materials
  • The merchant manufacturers segment is estimated to witness a lucrative CAGR over the forecast period
  • The generic segment is estimated to register the highest CAGR over the forecast period. The segment is driven by factors such as lower cost and expiration of patents of branded drugs
  • Asia Pacific is estimated to register a significant CAGR of 8.0% owing to the increasing number of pharmaceutical manufacturing plants in the region
  • Some of the key players in the API market are Mylan N.V.; Teva Pharmaceutical Industries Ltd.; Boehringer Ingelheim International GmbH; AbbVie Inc.; Merck & Co., Inc.; Cipla Inc.; Albemarle Corporation; Dr. Reddy’s Laboratories Ltd.; Bristol-Myers Squibb Company; Aurobindo Pharma; and Sun Pharmaceutical Industries Ltd.